NYSE$BLCO

Bausch + Lomb Corp · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Announced third-quarter 2023 results and raised full-year 2023 guidance.

Bausch + Lomb reported a 7% increase in revenue compared to the third quarter of 2022, driven by growth in the Vision Care and Surgical segments. The company also raised its full-year revenue and Adjusted EBITDA guidance.

  • Revenues of $1.007 Billion.
  • GAAP Net Loss Attributable to Bausch + Lomb Corporation of $84 Million.
  • Adjusted EBITDA (non-GAAP) of $187 Million.
  • Revenues Grew 7% as Reported and 8% on a Constant Currency Basis Compared to the Third Quarter of 2022, Driven by Growth in the Vision Care and Surgical Segments.

Headline financials

Total Revenue

$1.01B

Previous: $942M+6.9%
EPS (adj)

$0.22

Previous: $0.31-29.0%
Capital Expenditures

-$97M

Previous: -$125M+22.4%
Free Cash Flow

-$181M

Previous: -$143M-26.6%
Net Income

-$84M

Previous: -$18M-366.7%
Operating Income

$40M

Previous: $46M-13.0%
Gross Profit

$615M

Previous: $570M+7.9%
Cash & Equivalents

$355M

Previous: $287M+23.7%
Total Assets

$13.1B

Previous: $10.7B+22.2%
R&D Expense

$82M

No prior period
Stock-Based Comp

$16M

Previous: $18M-11.1%

Revenue & EPS history

Bausch + Lomb · Revenue · Quarterly

$1.01B

Q3 2023+6.9%vs Q3 2022
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

Bausch + Lomb · $1.01B total across 3 segments · Q3 2023

  • Vision Care
    $648M+8.4%
  • Surgical
    $185M+7.6%
  • Pharmaceuticals
    $174M+1.2%

Forward guidance

Bausch + Lomb raised its revenue and Adjusted EBITDA (non-GAAP) guidance for the full year of 2023.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-1.0%

Avg return

Earnings day

-1.8%

Avg return

5 days after

-1.0%

Avg return

30 days after

43%

9 / 21 earnings

Positive

+18.7%

Q4 2023

Best reaction

-15.7%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.8%+2.9%-1.0%
Q4 2025+0.2%+1.5%-11.3%
Q3 2025+2.1%+0.3%+6.5%
Q1 2025-15.7%-17.1%-16.4%
Q4 2024-0.3%-3.3%-4.8%
Q3 2024-2.3%-4.3%-4.5%
Q2 2024-0.1%-8.7%-2.6%
Q1 2024-4.7%-0.7%+5.5%
Q4 2023+18.7%+15.7%+10.8%
Q3 2023+4.6%+2.9%-4.3%
Q2 2023-2.5%-3.4%-7.2%
Q1 2023+0.1%+4.6%+4.4%
Q4 2020+0.4%-3.7%-14.1%
Q4 2022+0.4%-3.7%-14.1%
Q3 2022-4.9%+5.6%+7.9%
Q3 2021-4.9%+5.6%+7.9%
Q2 2022+4.7%+6.3%+1.2%
Q2 2021+4.7%+6.3%+1.2%
Q1 2022-6.8%-14.6%+5.0%
Q4 2021-6.8%-14.6%+5.0%
Q1 2021-6.8%-14.6%+5.0%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro